The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Factors that Influence Biologic Therapy Choices for Patients with Rheumatoid Arthritis

Factors that Influence Biologic Therapy Choices for Patients with Rheumatoid Arthritis

March 20, 2017 • By Michele B. Kaufman, PharmD, BCGP

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Michele B. Kaufman, PharmD, BCGP, is a freelance medical writer based in New York City and a pharmacist at New York Presbyterian Lower Manhattan Hospital.

You Might Also Like
  • Physician’s Choice: Factors That Influence First- & Second-Line Biologic Therapy in RA Patients
  • Rheumatoid Arthritis Research Provides New Insights on Risk Factors, Identification Tools, Intervention
  • New Developments in Rheumatoid Arthritis Treatment; Personalized Therapy for Patients Ultimate Goal
Explore This Issue
March 2017
Also By This Author
  • Atypical Fractures Associated with Bisphosphonates

References

  1. Monti S, Klersy C, Gorla R, et al. Factors influencing the choice of first- and second-line biologic therapy for the treatment of rheumatoid arthritis: Real-life data from the Italian LORHEN Registry. Clin Rheumatol. 2017 Jan 5. doi:10.1007/s10067-016-3528-y. [Epub ahead of print]
  2. Cohen S. Perspective: Comorbidities, older age may influence choice of abatacept. Healio. 2017 Jan 20.
  3. Hanlon JT, Perera S, Newman AB, et al. Potential drug–drug and drug–disease interactions in well-functioning community-dwelling older adults. J Clin Pharm Ther. 2017 Jan 22. doi: 10.1111/jcpt.12502. [Epub ahead of print]
  4. Can-Fite BioPharma Ltd. Can-Fite gears up for ACRobat, its Phase III trial of piclidenoson in rheumatoid arthritis. 2017 Feb 8.
  5. BioNap Inc. Can-Fite phase 3 RA program ready to start. 2017 Feb 8.

Pages: 1 2 3 | Single Page

Filed Under: Conditions, Drug Updates, Rheumatoid Arthritis Tagged With: biologic therapy, choice, drug, Medication, patient care, physician, Rheumatic Disease, Rheumatoid arthritis, rheumatologist, rheumatologyIssue: March 2017

You Might Also Like:
  • Physician’s Choice: Factors That Influence First- & Second-Line Biologic Therapy in RA Patients
  • Rheumatoid Arthritis Research Provides New Insights on Risk Factors, Identification Tools, Intervention
  • New Developments in Rheumatoid Arthritis Treatment; Personalized Therapy for Patients Ultimate Goal
  • Kidney Problems More Prevalent in Patients with Rheumatoid Arthritis

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)